22/08/2026
Strengthening International Collaboration in Breast Cancer Research
Yesterday, Cancer Research Malaysia (CRMY) was honoured to welcome Professor Laura Fejerman, Professor at the University of California Davis School of Medicine, USA. She is also Director of the Women’s Cancer Care and Research Program (WeCARE) at the UC Davis Comprehensive Cancer Center and leading leads the Latin America Genetics and Genomics of Breast Cancer Consortium (LAGENO BC). Her research focuses on how genetics influence risk and outcome of breast cancer.
Together with CRMY and Sunway University, we are working on an National Institutes of Health (NIH) funded project to better understand HER2 positive breast cancer using data from Latin American and Asian populations, including CRMY’s Malaysian Breast Cancer Genetic Study (MyBrCa). This is vital because these communities are often underrepresented in global research, yet face unique risks.
Her scientific talk at CRMY, “Advancing Breast Cancer Risk Prediction and Prevention in Hispanic/Latina Women”, provided valuable insights for our researchers. Her week-long visit to Malaysia also enabled in-person discussions with Professor Ho Weang Kee and Dr Tai Mei Chee, allowing us to exchange ideas, explore future research opportunities, and strengthen our collaboration in breast cancer risk prediction and prevention.
We are grateful for her visit and excited to continue this collaboration; bringing together genetics, biology, and prevention science to create more precise and inclusive approaches to breast cancer research.